Media Update: ERS: New data highlight Sanofi's scientific innovation and leadership in immune-mediated respiratory diseases

Source :: European Union News. August 27, 2024
Publication Year :: 2024
Abstract: Paris: Sanofi has issued the following press release: Sanofi will present twenty-four abstracts across approved and pipeline medicines at the European Respiratory Society (ERS) International Congress from September 7th-11th in [...]

Subjects :: Sanofi S.A. -- Innovations
Omalizumab -- Innovations
Diseases -- France
Pharmaceutical industry -- Innovations
Asthma
Business, international
Dupixent (Medication)

Tools